Distributor inventory | Tablet
Dapagliflozin 5 mg (tablet)
Type 2 diabetes mellitus (as an adjunct to diet and exercise) to improve glycaemic control; may be used alone or with other antidiabetic medicines as prescribed.
Dapagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys. This increases urinary glucose excretion, lowering blood glucose and producing mild diuresis.
Oral tablet; take exactly as prescribed, usually once daily, with or without food. Swallow whole with water; maintain hydration and follow diet/exercise advice. Do not stop or change dose without medical advice.
Common side effects of DAPAFREE-5 TAB may include:
Not for type 1 diabetes or diabetic ketoacidosis. Risk of dehydration/low blood pressure—use caution in elderly, on diuretics, or with low BP. May increase risk of genital/urinary infections; seek care for fever, pain on urination, genital symptoms. Rare but serious: ketoacidosis (even with normal sugars), Fournier’s gangrene, severe allergic reactions. Monitor kidney function; effectiveness reduces with significant renal impairment and use may be contraindicated at low eGFR—consult doctor. Hold during major surgery or acute serious illness; discuss sick-day rules.
